Praxis Precision Medicines (PRAX) had the highest return between December 27, 2023 and January 10, 2024 by a small-cap US stock, returning 70.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Praxis Precision Medicines (PRAX) | 12/27/2023 - 1/10/2024 | 70.53% |
Katapult Holdings Equity Warrants Exp 09 June 2026 (KPLTW) | 12/27/2023 - 1/10/2024 | 66% |
Clene (CLNNW) | 12/27/2023 - 1/10/2024 | 56.46% |
Sana Biotechnology (SANA) | 12/27/2023 - 1/10/2024 | 55.41% |
Yirendai (YRD) | 12/27/2023 - 1/10/2024 | 48.68% |
GeneDx (WGS) | 12/27/2023 - 1/10/2024 | 39.6% |
Ardelyx (ARDX) | 12/27/2023 - 1/10/2024 | 39.05% |
Dyne Therapeutics (DYN) | 12/27/2023 - 1/10/2024 | 35.79% |
Arcutis Biotherapeutics (ARQT) | 12/27/2023 - 1/10/2024 | 35.74% |
Iovance Biotherapeutics (IOVA) | 12/27/2023 - 1/10/2024 | 32.44% |
Rezolute (RZLT) | 12/27/2023 - 1/10/2024 | 31.11% |
Akebia Ther (AKBA) | 12/27/2023 - 1/10/2024 | 30.58% |
QuantaSing Group Limited American Depositary Shares (QSG) | 12/27/2023 - 1/10/2024 | 29.52% |
Capital Clean Energy Carriers (CCEC) | 12/27/2023 - 1/10/2024 | 27.74% |
Structure Therapeutics Inc American Depositary Shares (GPCR) | 12/27/2023 - 1/10/2024 | 27.66% |
GigaCloud Technology Inc Class A Ordinary Shares (GCT) | 12/27/2023 - 1/10/2024 | 27.59% |
Corvus Pharmaceuticals (CRVS) | 12/27/2023 - 1/10/2024 | 27.59% |
TMC the metals (TMC) | 12/27/2023 - 1/10/2024 | 27.19% |
Arrowhead Pharmaceuticals (ARWR) | 12/27/2023 - 1/10/2024 | 27.05% |
Verastem (VSTM) | 12/27/2023 - 1/10/2024 | 26.42% |
Aeva Technologies, Inc Common Stock (AEVA) | 12/27/2023 - 1/10/2024 | 26% |
Establishment Labs (ESTA) | 12/27/2023 - 1/10/2024 | 25.12% |
Heron Therapeuti (HRTX) | 12/27/2023 - 1/10/2024 | 25% |
Keros Therapeutics (KROS) | 12/27/2023 - 1/10/2024 | 24.76% |
Xeris Pharmaceuticals (XERS) | 12/27/2023 - 1/10/2024 | 24.44% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
